Production (Stage)
VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.59M | -3.75M | -3.70M | -3.50M | -3.61M |
| Total Depreciation and Amortization | 45.90K | 47.10K | 48.00K | 48.90K | 49.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 566.00K | 638.30K | 304.70K | 315.10K | 406.80K |
| Change in Net Operating Assets | 508.00K | 372.80K | 447.00K | 329.50K | 334.50K |
| Cash from Operations | -2.47M | -2.69M | -2.90M | -2.80M | -2.82M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.68M | 1.43M | 1.13M | -- | -- |
| Total Debt Repaid | -157.60K | -157.60K | -154.90K | -157.60K | -102.40K |
| Issuance of Common Stock | 857.30K | 302.40K | 37.60K | 37.60K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -174.60K | -106.30K | -59.40K | -- | -- |
| Cash from Financing | 1.60M | 1.07M | 692.20K | -89.00K | -75.90K |
| Foreign Exchange rate Adjustments | -34.40K | 600.00 | -12.40K | 0.00 | 10.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -911.30K | -1.62M | -2.22M | -2.89M | -2.88M |